Allegro Ophthalmics, LLC is a late-stage ophthalmic biopharmaceutical company focused on redefining the retina space with integrin inhibition therapy, a potential market-disrupting class of drugs for the treatment of retinal diseases.
Bristol-Myers Squibb
259 followers
Astellas Pharma
42 followers
NYU Langone Health
25 followers
West Pharmaceutical Services
8 followers
Curia Global
6 followers
AbbVie
275 followers
Navitus Health
3 followers
Xeris Pharmaceuticals
2 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers
Explore companies